FibroBiologics Chairman, CEO, & Founder Pete O'Heeron shares the journey that led him from clinical care to biopharma entrepreneurship, and he's joined by Chief Scientific Officer Hamid Khoja, Ph.D., who explains the manufacturing technology that's driving the company's exploitation of fibroblasts to develop regenerative therapies for indications ranging from degenerative disk disease and multiple sclerosis to cancer immunotherapies and therapeutics.
Business Of Biotech · 56 minutes · 9 months ago
Fibroblasts In Regenerative Medicine with FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja
Business, Management, & Employees Podcast
Benton Oakfield Inc. is an independent employee benefits brokerage committed to providing unsurpassed value and personalized service to every client. Join us as we explore many different business topics and opportunities while discussing business, management, and employees with...
Regenerative Medicine and Gene Therapy
Topics looking at the technique for correcting defective genes responsible for disease development.
Expanded Life & Business
The Expanded Life & Business podcast is all about empowering you to expand everything in your life: joy; wealth; health; love; business; by reframing your thinking, upgrading your mindset and applying energetics alongside savvy systems and practical aligned action taking.
Resolving Joint Paint Naturally with Regenerative Medicine
Are you experiencing joint pain? Are you tired of pain and pain killers? Is your doctor telling you that your only options are steroid injections and/or surgery? STOP. Don't operate, regenerate! On this podcast, Dr. Spence Jahner of Bozeman, Montana discusses the revolutionary na...
Oncology Today with Dr Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Cambridge Judge Business School Discussions on Management Science & Operations
Cutting-edge expert commentary, analysis and business insights on the management science and operational issues of the day from Cambridge Judge Business School's global faculty, associates and guest speakers.